THERAPEUTICS
Review: brand-name drugs are not more effective than generic versions for treating cardiovascular disease
| The first 150 words of the full text of this article appear below. |
QUESTION
Are generic drugs as effective as brand-name drugs for treating cardiovascular disease?
REVIEW SCOPE
Included studies compared 1 brand-name drug with
1 generic version for treating cardiovascular disease (ie, any condition affecting the heart or blood vessels) and reported
1 clinical efficacy or safety end point. Biologic products were excluded. Outcomes included vital signs (eg, heart rate, blood pressure, and urine output), clinical laboratory studies (eg, international normalised ratio, low-density lipoprotein, and urine electrolytes), patient morbidity or mortality, and health system use.
REVIEW METHODS
Medline, EMBASE/Excerpta Medica, and International Pharmaceutical Abstracts (1984 to Aug 2008) were searched for randomised controlled trials (RCTs) and observational studies published in English. Case studies, qualitative analyses, pharmacoeconomic evaluations, and surveys were excluded. 47 studies (38 RCTs) were included. RCT quality was assessed using the Jadad scale (range 0–5, mean 2.4). RCTs with data on means and standard deviations were included in a meta-analysis.
MAIN RESULTS
Equivalence based on the outcomes
University of Calgary, Calgary, Alberta, Canada
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
